Stratification and Treatment in Early Psychosis Study - PROMOTE

NCT07434973 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

586

Enrollment

OTHER

Sponsor class

Conditions

Clinical High Risk for Psychosis (CHR)
Clinical High Risk for Psychosis
Clinical High Risk for Developing Psychosis

Interventions

DRUG: Cannabidiol (CBD)
DRUG: Placebo

Sponsor

University of Oxford

Collaborators

[object Object]
[object Object]